Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001531769 | SCV001747042 | uncertain significance | not provided | 2021-04-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002071900 | SCV002482140 | benign | Primary ciliary dyskinesia | 2023-03-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002071900 | SCV003975686 | uncertain significance | Primary ciliary dyskinesia | 2023-05-16 | criteria provided, single submitter | clinical testing | The c.415G>A (p.E139K) alteration is located in exon 5 (coding exon 5) of the RPGR gene. This alteration results from a G to A substitution at nucleotide position 415, causing the glutamic acid (E) at amino acid position 139 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |